Clinical Trial Update: A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating ATG-010 in combination with chemotherapy with maintenance ATG-010 in Peripheral T-cell lymphoma and natural killer/T-cell lymphoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer T-cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• ATG-010

Snippet

Sponsor: Antengene Corporation | Conditions: Peripheral T-cell Lymphoma, NK/T-cell Lymphoma | Phase 1, Phase 2 | Status: TERMINATED